Auguste P, Tsertsvadze A, Pink J, Court R, Seedat F, Gurung T, Freeman K, Taylor-Phillips S, Walker C, Madan J, Kandala NB, Clarke A, Sutcliffe P. Accurate diagnosis of latent tuberculosis in children, people who are immunocompromised or at risk from immunosuppression and recent arrivals from countries with a high incidence of tuberculosis: systematic review and economic evaluation. Health technology assessment (Winchester, England). 2016;20(38).

The latest publication from a member of the Warwick Evidence team:

Rees CJ, Rajasekhar PT, Wilson A, Close H, Rutter MD, Saunders BP, East JE, Maier R, Moorghen M, Muhammad U, Hancock H, Jayaprakash A, MacDonald C, Ramadas A, Dhar A, Mason JM. Narrow band imaging optical diagnosis of small colorectal polyps in routine clinical practice: the Detect Inspect Characterise Resect and Discard 2 (DISCARD 2) study. Gut. 2016.

NICE has published draft guidance and its press release for

Ataluren for treating Duchenne muscular dystrophy caused by a nonsense mutation

https://www.nice.org.uk/news/press-and-media/nice-recommends-ataluren-for-treating-duchenne-muscular-dystrophy-caused-by-a-nonsense-mutation

A bibliometrics study, done as part of a wider project commissioned by the Macular Society by members of Warwick Evidence, found that the UK is one of the world’s leading producers of research into macular degeneration, one of the main causes of blindness. The number of citations to UK research publications showed that the quality of research is very good.

Royle P, Waugh N. Macular disease research in the United Kingdom 2011–2014: a bibliometric analysis of outputs, performance and coverage. BMC Research Notes 2015; 8:833 DOI 10.1186